Study guide

8.3 Correcting Non-Disclosure & Duty Compliance

USPTO Registration Examination Patent Bar

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview, Registration & MPEP Structure

1.1 Patent Bar Exam Format & Administration 1.2 Practitioner Qualifications & Eligibility 1.3 MPEP Structure & Effective Search Strategies

2 Chapter 2: Subject Matter Eligibility & Utility (35 U.S.C. § 101)

2.1 Patent-Eligible Subject Matter & Statutory Categories 2.2 Judicial Exceptions & the Alice/Mayo Framework 2.3 Utility Requirements & USPTO Utility Guidelines

3 Chapter 3: Novelty & Prior Art Under the AIA (35 U.S.C. § 102)

3.1 First-Inventor-to-File (FITF) & Effective Filing Dates 3.2 The One-Year Inventor Grace Period & Exceptions 3.3 Prior Art Types & Public Availability Standards

4 Chapter 4: Nonobviousness Analysis (35 U.S.C. § 103)

4.1 The Graham Factors & KSR Obviousness Framework 4.2 Combining Prior Art References & Motivation to Combine 4.3 Overcoming § 103 Rejections & Rule 132 Affidavits

5 Chapter 5: Specification & Disclosure Requirements (35 U.S.C. § 112(a))

5.1 Written Description Requirement 5.2 Enablement Requirement & Wands Factors 5.3 Best Mode Requirement & Current Post-AIA Status

6 Chapter 6: Claim Requirements & Definiteness (35 U.S.C. § 112(b)-(f))

6.1 Definiteness & Claim Precision 6.2 Independent & Dependent Claim Construction 6.3 Special Claim Formats: Means-Plus-Function & Markush Claims

7 Chapter 7: Application Types & Filing Procedures (MPEP Chapter 600)

7.1 Provisional Patent Applications 7.2 Nonprovisional Application Parts & Formalities 7.3 Inventor Oaths, Declarations & Assignments

8 Chapter 8: Duty of Disclosure & Information Disclosure Statements

8.1 Duty of Candor & Good Faith 8.2 Information Disclosure Statements (IDS) Requirements 8.3 Correcting Non-Disclosure & Duty Compliance

9 Chapter 9: Patent Prosecution & Office Action Responses (MPEP Chapter 700)

9.1 Initial Examination & Non-Final Office Actions 9.2 Statutory Deadlines & Extension of Time 9.3 Final Office Actions & Post-Final Practice

10 Chapter 10: Continuing Applications & Copendency

10.1 Continuation Applications 10.2 Divisional Applications 10.3 Continuation-in-Part (CIP) Applications & Priority Allocation

11 Chapter 11: Appeals & Interferences/Derivation (MPEP Chapter 1200 & 2300)

11.1 Ex Parte Appeals to the PTAB 11.2 PTAB Appeal Decisions & Judicial Review 11.3 Derivation Proceedings Under the AIA

12 Chapter 12: Post-Grant Proceedings & Corrections (MPEP Chapters 1400 & 2200)

12.1 Reissue Applications & Certificates of Correction 12.2 Ex Parte Reexamination & Supplemental Examination 12.3 Inter Partes Review (IPR) & Post-Grant Review (PGR)

13 Chapter 13: Patent Term, Maintenance Fees & Ownership

13.1 Patent Term Calculation & Patent Term Adjustment (PTA) 13.2 Maintenance Fees & Expiration 13.3 Inventorship, Ownership & Assignment Recordation 13.4 Patent Term Extension Under 35 U.S.C. § 156

14 Chapter 14: International Patent Practice & PCT (MPEP Chapter 1800)

14.1 The Patent Cooperation Treaty (PCT) Overview 14.2 PCT International Phase & Chapter I / Chapter II 14.3 National Phase Entry Under 35 U.S.C. § 371

15 Chapter 15: Special Patent Categories & Professional Conduct

15.1 Design Patents & Plant Patents 15.2 USPTO Rules of Professional Conduct 15.3 Patent Bar Exam Strategy & Open-Book Navigation Tips

16 Chapter 16: Security, Access, Representation & Filing Mechanics

16.1 Secrecy, Application Access & Foreign Filing Licenses 16.2 Representation, Power of Attorney & Correspondence 16.3 Filing Receipt, Certificates of Transmission & Signatures

17 Chapter 17: Restriction, Publication, Allowance & Office Authority

17.1 Restriction, Election, Rejoinder & Double Patenting 17.2 Publication, Preissuance Submissions & Protests 17.3 Allowance, Issue Fee & Withdrawal from Issue 17.4 Examiner Interviews, Petitions & Office Authority

18 Chapter 18: Biotechnology Disclosure & Patent Prosecution Highway

18.1 Biological Deposits & Sequence Listings 18.2 Global/IP5 Patent Prosecution Highway

19 Chapter 19: AIA Trial Practice Under the Consolidated Guide

19.1 AIA Trial Petitions, Preliminary Response & Institution 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision

8.3 Correcting Non-Disclosure & Duty Compliance

Key Takeaways Explain This Topic AI

Material information from related U.S., foreign, and PCT matters must be evaluated and made available to the examiner, but MPEP 609.03 can make a separate IDS unnecessary for ISR documents already present in a § 371 file.

Rule 56 applies in reissue and Rule 1.555 applies in ex parte reexamination; PTAB trial participants separately owe candor and good faith under Rule 42.11.

An applicant may file later IDS submissions before issue, but each submission must independently satisfy the applicable timing, fee, certification, and content rules.

After the issue fee is paid, newly discovered art may require withdrawal from issue with an RCE or use of the QPIDS procedure when its conditions are met.

Rule 1.97(h) says an IDS does not represent that a search was made, while Rule 1.97(i) says it is not an admission that the information is material.

Last updated: August 2026

Compliance with the duty of disclosure is not a one-time event; it is an ongoing responsibility that spans related U.S. applications, foreign counterpart prosecutions, and post-issuance proceedings. On the Patent Bar exam, test questions frequently probe how applicants must handle prior art discovered late in prosecution, cross-citation obligations between copending applications, post-issuance disclosure rules, and the legal effect of submitting disclosures under 37 C.F.R. § 1.97(h) .

Cross-Citation in Copending Applications & PCT Reports

When an applicant or assignee maintains multiple copending patent applications that share related subject matter, prior art cited in one application may be highly material to the patentability of claims in another application. The duty of disclosure under 37 C.F.R. § 1.56 requires that material information cited by an examiner or foreign patent office in one proceeding be promptly brought to the attention of the examiner in all related copending U.S. applications.

Key Scenarios Tested on the Exam:

Copending U.S. Applications : If Examiner A cites a material prior art reference in Parent Application X, the practitioner prosecuting Copending Application Y (which claims related subject matter) must file an IDS disclosing that reference in Application Y, provided the reference is material to Y's claims.

PCT international search reports in a national stage : The examiner considers U.S. patent documents cited in the ISR when they are electronically in the file. Other ISR documents are considered when the national-stage file indicates that the ISR and required copies are present. A separate IDS listing is not required for consideration in that circumstance, although a separate compliant list may be needed for citations to print on the patent; missing required copies remain the applicant’s burden.

Foreign Counterpart Prosecutions : Prior art cited by foreign examiners (e.g., EPO, JPO, KIPO) in counterpart applications must be evaluated immediately. If material, references must be disclosed to the USPTO, typically utilizing the 3-month window provided by 37 C.F.R. § 1.97(e)(1) to avoid statutory fees.

Post-Grant Proceedings & Ongoing Duty of Disclosure

The duty of candor and good faith does not terminate when a patent issues if the patent subsequently enters post-grant administrative proceedings at the USPTO:

Post-Grant Proceeding Governing Rule Scope of Duty of Disclosure

Reissue Applications 37 C.F.R. § 1.175 / § 1.178 Full Rule 56 duty applies. Applicants must disclose all prior art cited during original prosecution and any new material art discovered since issuance.

Ex Parte Reexamination 37 C.F.R. § 1.555 Patent owners and practitioners have a continuous duty to disclose material patents and printed publications during reexamination.

Inter Partes Review (IPR) & Post-Grant Review (PGR) 37 C.F.R. § 42.11 Parties and practitioners before the Patent Trial and Appeal Board (PTAB) owe a duty of candor and good faith in all representations and filings.

In reissue and reexamination proceedings, failing to disclose material prior art known during the proceeding can result in administrative rejection or subsequent judicial invalidation / unenforceability.

Supplemental IDS & Post-Issue Fee Practice

During application prosecution, an applicant may discover additional references after having already filed an initial IDS. An applicant may submit an additional IDS before issue, but each submission independently must satisfy the applicable timing, fee, certification, and content requirements. Rule 1.97(i) is not authority for a special supplemental-IDS procedure ; it provides that filing an IDS is not an admission that the cited information is material.

Disclosing Prior Art After Issue Fee Payment

Once the Issue Fee has been paid, the USPTO lacks jurisdiction to consider an IDS under normal prosecution rules. If material prior art is discovered after issue fee payment, the applicant has two primary procedural mechanisms:

Petition to Withdraw Application from Issue under 37 C.F.R. § 1.313(c)(2) :

The applicant files a petition under § 1.313(c)(2) requesting that the application be withdrawn from issue for the express purpose of filing a Request for Continued Examination (RCE) under § 1.114.

The petition is accompanied by the RCE fee, an RCE submission, and the new IDS.

Filing the RCE reopens prosecution, placing the application back into Tier 1 for IDS purposes.

Quick Path Information Disclosure Statement (QPIDS) Program :

Designed to avoid unnecessary prosecution delay when material art is discovered post-issue fee payment.

The applicant files a QPIDS submission containing: (a) a petition to withdraw from issue under § 1.313(c)(3), (b) an IDS with a § 1.97(e) certification, (c) the statutory IDS fee, and (d) a conditional RCE fee.

If the examiner reviews the IDS and determines that no reference requires reopening prosecution, the examiner initials the IDS, issues a corrected Notice of Allowance, and the conditional RCE fee is refunded .

If the examiner determines that a reference requires reopening prosecution, the petition to withdraw is granted, the conditional RCE fee is processed, and prosecution reopens.

Non-Admission Rules & Reference Withdrawal

Applicants sometimes worry that submitting a large volume of prior art in an IDS will be construed by courts as an admission that the cited references are material or constitute prior art against the invention. Regulation 37 C.F.R. § 1.97(h) directly addresses this concern:

37 C.F.R. § 1.97(h) : "The filing of an information disclosure statement shall not be construed to be a representation that a search has been made or that the information cited in the statement is, or is considered to be, material to patentability."

Legal Impact of § 1.97(h):

No Search Representation : Submitting an IDS does not represent that a comprehensive prior art search was conducted.

No Admission of Prior Art Status : Listing a document on Form PTO/SB/08a does not automatically turn that document into prior art under 35 U.S.C. 102 (e.g., if a cited document was authored by the inventor within the 1-year grace period).

Express Admissions : While merely listing a reference is not an admission, making explicit technical statements in the IDS narrative or specification admitting that a reference is "prior art" will bind the applicant as an express admission.

Loading diagram... Post-Notice of Allowance Prior Art Disclosure Workflow (QPIDS vs RCE)